• news.cision.com/
  • aXichem AB/
  • aXichem signs agreement with Pharmafoods regarding marketing and distribution of aXivite in Spain and Portugal

aXichem signs agreement with Pharmafoods regarding marketing and distribution of aXivite in Spain and Portugal

Report this content

aXichem AB (publ), a developer of natural analogue industrial compounds, has entered into a marketing and distribution agreement with the Spanish company Pharmafoods, a subsidiary of Comercial Química Massó, and awarded them exclusivity in the Spanish and Portuguese markets for the aXivite product.
 

As previously announced aXichem has terminated its agreement with Tecom Ingredients and would like to take this opportunity to thank Tecom Ingredients for their work in introducing aXivite in the Spanish market.

“We are very happy to welcome Pharmafoods in our distribution network. Due to their outstanding dietary supplement and fine chemical distribution experience, Pharmafoods salesforce shall support our customers with high skill personnel in formulating dietary solutions with aXivite.”, says Lucas Altepost, vice President and VP Sales and Marketing at aXichem. 

Pharmafoods is a company dedicated to the distribution of special ingredients for dietary supplements, food, pharmaceutical and cosmetic sectors. Since its origins in 2001, Pharmafoods has continued to represent prestigious national and international companies. Pharmafoods distributes only branded, designed products and provides high technical support and solid documentation.

More about Pharmafoods at www.pharmafoods.es

The Spanish market for food supplements ingredients amounted in 2017 to €300 million according to Nutrition Business Journal, and holds an interesting growth potential, considering the size of Spain’s population. For Portugal the corresponding market amounted to €80 million in2020 according to StatistaThe market is expected to grow annually by 8.51%.

This press release was submitted by the contact person below on 3 June 2021, at 08:30 CET.

Torsten Helsing, CEO, aXichem, Ph +46 46-780 06 73. Email: torsten.helsing@axichem.se

aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenylcapsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB Certifiedadviser@redeye.se +46 (0)8 121 576 90. Read more about the company at www.axichem.se